Showing results (2221-2230 of 6,714) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|July 11, 2018
Primary effusion lymphoma: current perspectivesMayur Narkhede, Shagun Arora, Chaitra UjjaniOncotargets and Therapy|June 21, 2018
Prognostic value of spleen tyrosine kinase in human solid tumorsBeibei Ni, Shi Li, Yang Liu, et al.Oncotargets and Therapy|June 22, 2018
Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancerGuoyu Huang, Guanbao ZhuOncotargets and Therapy|June 22, 2018
Twenty-gene-based prognostic model predicts lung adenocarcinoma survivalKai Zhao, Zulei Li, Hui TianOncotargets and Therapy|June 29, 2018
Whole-body MRI versus 18F-FDG PET/CT for pretherapeutic assessment and staging of lymphoma: a meta-analysisDanyang Wang, Yanlei Huo, Suyun Chen, et al.Oncotargets and Therapy|June 27, 2018
MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRASJunkai Chang, Weibo Xu, Xinyi Du, et al.Oncotargets and Therapy|June 27, 2018
Downregulation of ribophorin II suppresses tumor growth, migration, and invasion of nasopharyngeal carcinomaFeilong Hong, Yong Li, Haifeng Ni, et al.Oncotargets and Therapy|June 1, 2018
Indirubin inhibits cell proliferation, migration, invasion and angiogenesis in tumor-derived endothelial cellsZhuohong Li, Chaofu Zhu, Baiping An, et al.Oncotargets and Therapy|June 1, 2018
Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cellsMan Wu, Guanren Zhao, Xiaomei Zhuang, et al.Oncotargets and Therapy|June 1, 2018
Downregulation of STARD8 in gastric cancer and its involvement in gastric cancer progressionShuanglong Zhang, Xiaojing Chang, Jinguo Ma, et al.Pageof 672